Multiple Sclerosis Information:FDA Approves New Drug To Treatment MS Patients

0
164
Multiple Sclerosis Information:FDA Approves New Drug To Cure MS Patients

The U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by the FDA for PPMS. Ocrevus is an intravenous infusion given by a health care professional.

“Multiple sclerosis can have a profound impact on a person’s life,” said Billy Dunn, M.D., director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research. “This therapy not only provides another multiple sclerosis (MS) treatment option for those with relapsing MS, but for the first time provides an approved therapy for those with primary progressive multiple sclerosis (MS) .”